Gracell Biotechnologies (GRCL) Assets

Price: $10.25
Market Cap: $989.87M
Avg Volume: 1.46M
Country: CN
Industry: Biotechnology
Sector: Healthcare
Beta: -0.345
52W Range: $1.4-10.435
Website: Gracell Biotechnologies

Gracell Biotechnologies Asset Metrics Summary

According to Gracell Biotechnologies's latest annual financial reports, the company's asset profile is as follows:

Total Assets

Gracell Biotechnologies's total assets amount to $1.66B. This is divided into:

  • Total Current Assets: $1.50B
  • Total Non-current Assets: $160.52M
  • Net Receivables: $-
  • Inventory: $-26.33M
  • Cash and Short-term Investments: $1.46B
  • Property, Plant, and Equipment (Net): $144.67M
  • Long-term Investments: $-
  • Goodwill and Intangible Assets: $-

Asset Ratios and Metrics

To better understand Gracell Biotechnologies's asset management, we can look at several key ratios:

  • Return on Assets (ROA): -36.68% - this indicates how profitable a company is relative to its total assets.
  • Asset Turnover: 0.00 - this shows how efficiently a company uses its assets to generate sales.
  • Current Ratio: 6.78 - this measures a company's ability to pay short-term obligations with its current assets.
  • Quick Ratio: 6.90 - this indicates a company's ability to meet short-term obligations with its most liquid assets.
  • Cash Ratio: 6.59 - this measures a company's ability to pay off short-term liabilities with its cash and cash equivalents.

These metrics provide insight into Gracell Biotechnologies's asset efficiency and liquidity. For a comprehensive understanding of the company's financial health, it's important to consider these asset metrics alongside other financial indicators and industry benchmarks.

Total Assets

$1.66B

Total Current Assets

$1.50B

Total Non-current Assets

$160.52M

Net Receivables

$-

Inventory

$-26.33M

Cash and Short-term Investments

$1.46B

Property, Plant, and Equipment (Net)

$144.67M

Long-term Investments

$-

Goodwill and Intangible Assets

$-

Return on Assets

-36.68%

Asset Turnover

0.00

Current Ratio

6.78

Gracell Biotechnologies Historical Asset Metrics
Total Assets
Total Current Assets
Total Non-current Assets
$2.50B$2.50B$2.00B$2.00B$1.50B$1.50B$1.00B$1.00B$500.00M$500.00M$0.00$0.00Asset Metrics20192019Jul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '22
Historical Return on Assets
8.19%8.19%-0.00%-0.00%-8.19%-8.19%-16.37%-16.37%-24.56%-24.56%-32.75%-32.75%-40.93%-40.93%Return on Assets20192019Jul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023
Historical Total Assets Growth
179.44%179.44%113.09%113.09%46.74%46.74%-19.60%-19.60%Total Assets Growth20192019Jul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023

Gracell Biotechnologies Historical Assets

The table below shows various asset metrics for each year, with the latest data available for the last fiscal year 2022.

Year Total Assets Total Current Assets Total Non-current Assets Net Receivables Inventory Cash and Short-term Investments Property, Plant, Equipment (Net) Long-term Investments Goodwill and Intangible Assets Return on Assets Asset Turnover Current Ratio Quick Ratio Cash Ratio
2022 $1.66B $1.50B $160.52M $- $-26.33M $1.46B $144.67M $- $- -0.37 0.00 6.78 6.90 6.59
2021 $2.06B $1.89B $175.06M $0 $8.70M $1.83B $173.44M $- $- -0.23 0.00 12.15 12.10 11.79
2020 $964.95M $815.47M $149.48M $- $-30.96M $773.05M $119.08M $- $- -0.20 0.00 8.73 9.07 8.08
2019 $412.22M $340.35M $71.86M $- $9.39M $316.26M $71.86M $- $- -0.32 0.00 18.74 18.22 17.18
2018 $148.52M $127.96M $20.56M $- $7.70M $113.89M $20.56M $- $- -0.41 0.00 17.20 16.16 1.60

Related Metrics

Explore detailed financial metrics and analysis for GRCL.